SCHEMBL7873594

SCHEMBL7873594

CNC(N)=NC(=O)c1cc2ccc(Oc3ccc(N)cc3)cc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.40
FLT3 P36888 4/20 0.39
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
ALOX15 P16050 1/20 0.39
KMT2A Q03164 3/20 0.38
LGALS8 O00214 1/20 0.38
HRH4 Q9H3N8 2/20 0.37
CHEK2 O96017 1/20 0.37
HDAC3 O15379 1/20 0.37
BRAF P15056 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882069 0.91 XDH (0.51) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7877886 0.90 XDH (0.41) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7885071 0.89 XDH (0.39) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7881191 0.88 KMT2A (0.39) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7881911 0.87 SIRT2 (0.38) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7873687 0.87 HRH4 (0.48) FLT3PDGFRBPDGFRAALOX15HRH4
SCHEMBL7881047 0.86 LGALS8 (0.42) XDHPDGFRBPDGFRAKMT2ALGALS8
SCHEMBL7873340 0.86 KMT2A (0.43) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7879701 0.86 ROCK2 (0.41) XDHFLT3PDGFRBPDGFRAALOX15
SCHEMBL7877900 0.86 FLT3 (0.54) FLT3PDGFRBPDGFRAKMT2AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed